Medtronic Structural Heart ICD-10 Coding for Hospitals

Total Page:16

File Type:pdf, Size:1020Kb

Medtronic Structural Heart ICD-10 Coding for Hospitals Medtronic Structural Heart ICD-10 Coding for Hospitals Linda Holtzman RHIA, CCS, CCS-P, CPC,COC Clarity Coding January 2016 Disclaimer Reimbursement information provided by Medtronic is for illustrative purposes only and does not constitute legal advice. Information provided is gathered from third party sources and is subject to change without notice due to frequently changing laws, rules and regulations. Medtronic makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other third party payers as to the correct form of billing or the amount that will be paid to providers of service. The provider of service has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided. Please contact your local payers, reimbursement specialists and/or legal counsel for interpretation of coding, coverage, and payment policies. Medtronic does not promote the use of its products outside FDA-approved labeling. 2 Topics Background and Framework ICD-10-CM Diagnosis Codes ICD-10-PCS Procedure Codes DRG Impact Appendix : Key Resources Questions Attachment : Diagnosis Code Crosswalks 3 Background and Framework 4 Effective Date ICD-10 went into effect October 1, 2015. Use of ICD-10 in the United States was formally proposed in August 2008 and finalized in January 2009. Implementation of ICD-10 was initially scheduled for October 2013 and has been postponed twice since then. ICD-10 is effective by date of discharge, not by date of admission. ICD-10-CM for diagnosis codes and ICD-10-PCS for procedure codes go into effect together on the same date. 5 Who Uses What Hospitals, physicians and all other providers must use ICD-10 diagnosis codes. Hospitals must also use ICD-10-PCS procedure codes for inpatient cases. Implementation of ICD-10 does not affect use of CPT. Provider Setting Diagnoses Procedures Hospitals Inpatient ICD-10-CM ICD-10-PCS Hospitals Outpatient ICD-10-CM CPT Physicians Facility/Office ICD-10-CM CPT ASCs Outpatient ICD-10-CM CPT 6 ICD-10 Coding Guidelines Guidelines for use of ICD-10 are available from multiple credible sources. Instructions within the ICD-10 codebook itself The ICD-10 Official Guidelines for Coding and Reporting Coding Clinic and AHA Coding Clinic Advisor AHA ICD-10-CM and ICD-10-PCS Coding Handbook Minutes from meetings of the ICD-10 Coordination and Maintenance Committee ICD-10-PCS Reference Manual AHIMA ICD-10-PCS: An Applied Approach 7 General Equivalence Mappings General Equivalence Mappings (GEMs) are useful tools for going back-and-forth between ICD-9 and ICD-10 codes, for both diagnoses and procedures. Forward GEMs go from ICD-9 to ICD-10; Backward GEMs go from ICD-10 to ICD-9. The GEMs can be found at: http://www.cdc.gov/nchs/icd/icd10cm.htm#icd2105 http://www.cms.gov/Medicare/Coding/ICD10/ 2015-ICD-10-CM-and-GEMs.html GEMs can be a good starting place. But NCHS and CMS strongly recommend coding directly from the ICD-10 codebooks, as studies have consistently indicated that this is most accurate. 8 ICD-10-CM Diagnosis Codes 9 Diagnosis Code Structure Codes are organized by chapter, mostly by body system. The chapters are virtually identical to those in ICD-9-CM. Codes are alpha-numeric and can be 3 to 7 digits long. CategoryDecimal Details Extension T82.223A T 8 2 2 2 3 A Leakage of biological heart valve graft, initial encounter alpha number alpha or number Q21.3 Q 2 1 3 Tetralogy of Fallot I25.10 Atherosclerotic heart disease I 2 5 1 0 of native coronary artery without angina pectoris 10 Volume of Diagnosis Codes ICD-10-CM has far more diagnosis ICD-9-CM codes than ICD-9-CM and provides a 14,567 codes greater level of specificity. ICD-10-CM Example: Non-rheumatic aortic valve disorders 69,823 codes ICD-9-CM ICD-10-CM I35.0 Non-rheumatic aortic (valve) stenosis I35.1 Non-rheumatic aortic (valve) insufficiency (regurgitation) Aortic valve 424.1 I35.2 Non-rheumatic aortic (valve) stenosis with insufficiency disorders I35.8 Other non-rheumatic aortic valve disorders I35.9 Non-rheumatic aortic valve disorder, unspecified Example: Mechanical complication of coronary artery bypass graft ICD-9-CM ICD-10-CM T82.211A Breakdown (mechanical) of coronary artery bypass graft, initial encounter Mechanical complication T82.212A Displacement of coronary artery bypass graft, initial encounter 996.03 due to coronary artery bypass T82.213A Leakage of coronary artery bypass graft, initial encounter graft T82.218A Other mechanical complication of coronary artery bypass graft, initial encounter 11 Valve Disorders Aortic valve stenosis and pulmonary valve disorders default to non-rheumatic. Mitral valve stenosis and tricuspid valve disorders default to rheumatic. Valve disease with involvement of multiple valves (aortic, mitral, tricuspid) is coded as rheumatic whether documented as rheumatic or not. 12 Angina and Coronary Artery Disease Angina codes (I20) are not assigned separately if the patient also has CAD. A combination code is used instead. A cause-and-effect relationship between angina and CAD can be assumed.1 To code CAD in ICD-10-CM, the coder must know three things: Does the patient also have angina? What kind of vessel has coronary atherosclerosis? What kind of angina? Code Description Notes Atherosclerotic heart disease of native coronary artery I25.10 Use for CAD or ASHD NOS without angina without angina pectoris Atherosclerotic heart disease of native coronary artery I25.119 Use for CAD or ASHD NOS with angina with unspecified angina pectoris Atherosclerosis of coronary artery bypass graft(s), I25.709 Use for CAD or ASHD with CABG with angina unspecified, with unspecified angina pectoris 1. ICD-10-CM Official Guidelines for Coding and Reporting (Diagnoses), FY 2015, p.42 13 Device Complications Mechanical complication is defined the same way in ICD-10-CM as it is in ICD-9-CM. ICD-10-CM differentiates between mechanical complications of artificial valves and tissue valves. Code Description Notes Breakdown (mechanical) of heart valve prosthesis, initial T82.01xA Artificial valve devices (metallic) encounter Breakdown (mechanical) of biological heart valve graft, Tissue valve devices, including bio- T82.221A initial encounter prosthetics Occlusion of a coronary artery bypass graft due to atherosclerosis is not coded as a complication. Use I25.7 instead.2 ICD-10-CM has a specific code for infection of heart valve device. Code Description Notes Infection and inflammatory reaction due to cardiac valve T82.6xxA Heart valve devices (any type) prosthesis, initial encounter Infection and inflammatory reaction due to other cardiac T82.7xxA All other cardiac devices and vascular devices, implants, and grafts, initial encounter 2. AHA ICD-10-CM and ICD-10-PCS Coding Handbook, FY 2015, p.535 14 Device Complications For other (non-mechanical) complications, ICD-10-CM differentiates the type of complication but not the type of device. ICD-9-CM ICD-10-CM Other complication T82.817A Embolism of cardiac prosthetic devices, implants and grafts, initial encounter 996.71 due to heart valve T82.827A Fibrosis of cardiac prosthetic devices, implants and grafts, initial encounter prosthesis T82.837A Hemorrhage of cardiac prosthetic devices, implants, grafts, initial encounter Other complication T82.847A Pain from cardiac prosthetic devices, implants and grafts, initial encounter 996.72 due to other T82.857A Stenosis of cardiac prosthetic devices, implants and grafts, initial encounter cardiac device, T82.867A Thrombosis of cardiac prosthetic devices, implants, grafts, initial encounter implant and graft (including coronary Other specified complication of cardiac prosthetic devices, implants and T82.897A artery bypass graft) grafts, initial encounter Proposals have already been made to ICD-10 C&M Committee to create new codes that provide more detail on the specific device. 15 Status and Encounter ICD-9-CM ICD-10-CM Z95.3 Presence of xenogenic heart valve V42.2 Heart valve replaced by transplant (tissue) Z95.4 Presence of other heart valve replacement V43.3 Heart valve replaced by other means (artificial) Z95.2 Presence of prosthetic heart valve V45.81 Aortocoronary bypass status Z95.1 Presence of aortocoronary bypass graft Encounter for adjustment and management of V53.39 Fitting and adjustment of other cardiac device Z45.09 other cardiac device Code Z95.2 is used for the presence of a mechanical heart valve. It is also the default code for the presence of any non- native valve. Code Z95.3 is used for the presence of animal tissue valves, including bioprosthetics, eg. CoreValve. Code Z95.4 is used for the presence of a homograft valve. Expected end-of-life for a heart valve graft is not coded as a complication. Use Z45.09 instead.3 3. Coding Clinic, 2nd Q 2008 16 TAVR: Valve-in-Valve In mid-2015, transcatheter aortic valve replacement received a new indication for treatment of “failure” of a previously placed bioprosthetic valve. For coding purposes, the key factor is whether the “failure” is a complication or an expected occurrence. Scenario ICD-10-CM Malposition or displacement of T82.222A Displacement of biological heart valve graft, initial encounter previously placed valve Premature stenosis of the Stenosis of cardiac prosthetic devices, implants and grafts, T82.857A previously placed valve initial encounter Premature regurgitation of the T82.223A Leakage of biological heart valve graft, initial encounter previously placed valve Expected degeneration of Encounter for adjustment and management of other cardiac Z45.09 previously placed valve (end-of-life) device Seventh digit “A” is correct for the complication codes because active treatment is provided for the valve failure.4 4. Coding Clinic, 1st Q 2015 17 ICD-10-PCS Procedure Codes 18 ICD-10-PCS Format Codes are alpha-numeric and are always 7 digits long.
Recommended publications
  • Myocardiial Protection Strategy Utilizing Retrograde Cardioplegia
    Myocardial Protection Strategy Utilizing Retrograde Cardioplegia Item Type text; Electronic Thesis Authors Karbasi, Michael Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the College of Medicine - Phoenix, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 25/09/2021 11:23:01 Link to Item http://hdl.handle.net/10150/281195 Myocardial Protection Strategy Utilizing Retrograde Cardioplegia for Neonatal Arterial Switch Operations Michael Karbasi1, John Nigro, M.D.2,3, Bradford Sanders, CCP,, MS2,3, Cyrus Kosar, MS4, Brigham C. Willis, M.D.1,2,3 1 University of Arizona, College of Medicine-Phoenix; 2Children’s Heart Center, Phoenix Children’s Hospital, Phoenix, AZ; 3Eller Congenital Heart Center at St. Joseph’s Hospital and Medical Center, Phoenix, AZ; and 4Institute for Aging Research in Affiliation with Harvard Medical School ABSTRACT RESULTS 30.0 Introduction: Myocardial protection strategies are a central component of neonatal arterial switch operations. Traditionally antegrade cardioplegia 25.0 through the aortic root has been the method of delivery, but use of retrograde cardioplegia via the coronary sinus has become the standard 20.0 of practice by many in the field. Methods: After obtaining IRB approval 15.0 Retrograde and informed consent, a retrospective chart review was done to assess Days Antegrade outcomes between 48 patients receiving antegrade (n= 5) and retrograde 10.0 (n= 43) cardioplegia during neonatal switch operations. Preoperative demographics and postoperative outcomes were compared between the 5.0 two groups and compared with historical studies.
    [Show full text]
  • Surgical Management of Transcatheter Heart Valves
    Corporate Medical Policy Surgical Management of Transcatheter Heart Valves File Name: surgica l_management_of_transcatheter_heart_valves Origination: 1/2011 Last CAP Review: 6/2021 Next CAP Review: 6/2022 Last Review: 6/2021 Description of Procedure or Service As the proportion of older adults increases in the U.S. population, the incidence of degenerative heart valve disease also increases. Aortic stenosis and mitra l regurgita tion are the most common valvular disorders in adults aged 70 years and older. For patients with severe valve disease, heart valve repair or replacement involving open heart surgery can improve functional status and qua lity of life. A variety of conventional mechanical and bioprosthetic heart valves are readily available. However, some individuals, due to advanced age or co-morbidities, are considered too high risk for open heart surgery. Alternatives to the open heart approach to heart valve replacement are currently being explored. Transcatheter heart valve replacement and repair are relatively new interventional procedures involving the insertion of an artificial heart valve or repair device using a catheter, rather than through open heart surgery, or surgical valve replacement (SAVR). The point of entry is typically either the femoral vein (antegrade) or femora l artery (retrograde), or directly through the myocardium via the apical region of the heart. For pulmonic and aortic valve replacement surgery, an expandable prosthetic heart valve is crimped onto a catheter and then delivered and deployed at the site of the diseased native valve. For valve repair, a small device is delivered by catheter to the mitral valve where the faulty leaflets are clipped together to reduce regurgitation.
    [Show full text]
  • Severe Aortic Stenosis and the Valve Replacement Procedure
    Severe Aortic Stenosis and the Valve Replacement Procedure A Guide for Patients and their Families If you’ve been diagnosed with severe aortic stenosis, you probably have a lot of questions and concerns. The information in this booklet will help you learn more about your heart, severe aortic stenosis, and treatment options. Your heart team will recommend which treatment option is best for you. Please talk with them about any questions you have. Table of Contents 4 About Your Heart 5 What Is Severe Aortic Stenosis? 5 What Causes Severe Aortic Stenosis? 7 What Are the Symptoms of Severe Aortic Stenosis? 8 Treatment Options for Severe Aortic Stenosis 10 Before a TAVR Procedure 12 What Are the Risks of TAVR? 2 3 About Your Heart What Is Severe See the difference between healthy and The heart is a muscle about the size of your fist. It is a pump that works nonstop to Aortic Stenosis? diseased valves send oxygen-rich blood throughout your entire body. The heart is made up of four The aortic valve is made up of two or three chambers and four valves. The contractions (heartbeats) of the four chambers push Healthy Valve the blood through the valves and out to your body. tissue flaps, called leaflets. Healthy valves open at every heart contraction, allowing blood to flow forward to the next chamber, and then close tightly to prevent blood from backing Pulmonic controls the flow of Aortic controls the flow of blood up. Blood flows in one direction only. This is Valve blood to the lungs Valve out of your heart to the important for a healthy heart.
    [Show full text]
  • Comparison of Del Nido Cardioplegia
    ORIGINAL ARTICLE Braz J Cardiovasc Surg 2021;36(2):158-64 Comparison of Del Nido Cardioplegia and Blood Cardioplegia in Terms of Development of Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting Umut Serhat Sanrı1, MD; Kadir Kaan Özsin1, MD; Faruk Toktaş1, MD; Şenol Yavuz1, MD DOI: 10.21470/1678-9741-2020-0047 Abstract length of hospital stay remain significantly higher in the BC group Objective: Del Nido cardioplegia (DNC) has been used in (P=0.044, P<0.001, respectively). In addition, the aortic cross-clamp pediatric cardiac surgery for many years with a single dose time and the cardioplegia volume delivered were significantly application and its usage in adult cardiac surgery has been lower in the DNC group (P=0.042, P<0.001, respectively). In increasing in recent years, with results being published. In multivariate logistic regression analysis, only higher cardioplegia this study, we aimed to investigate the effect of DNC on the volume was determined as an independent predictor for PoAF development of postoperative atrial fibrillation (PoAF). development (OR 1.001; 95% CI 1.000-1.001; P=0.033). We did not Methods: In this retrospective observational comparative found difference between groups in terms of troponin T, inotropic study, 255 patients who underwent isolated on-pump coronary drug support, need for intraaortic balloon pump and mortality. artery bypass grafting, between January 2019 and November Conclusion: This study showed that DNC can be used safely 2019, were enrolled. The patients were divided into two groups: in adult coronary bypass surgery and PoAF development effect DNC (n=132) and blood cardioplegia (BC) (n=123).
    [Show full text]
  • A Common Occurrence After Coronary Bypass Surgery
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector lACC Vol. 15, No.6 1261 May 1990:1261-9 Acute Myocardial Dysfunction and Recovery: A Common Occurrence After Coronary Bypass Surgery WARREN M. BREISBLATT, MD, FACC, KEITH L. STEIN, MD, CYNTHIA J. WOLFE, RN, WILLIAM P. FOLLANSBEE, MD, FACC, JOHN CAPOZZI, CNMT, JOHN M. ARMITAGE, MD, ROBERT L. HARDESTY, MD, FACC Pittsburgh, Pennsylvania To evaluate whether acute myocardial dysfunction was min after coronary bypass and showed complete recovery common in the early postoperative period, serial hemody• within 48 h. Left ventricular end-systolic and end-diastolic namic measurements and radionuclide evaluation of ven• volume index increased significantly postoperatively, but tricular function were performed before and after opera• recovery in left ventricular ejection fraction was mostly due tion in 24 patients undergoing elective coronary bypass to decreases in end-systolic volume index (50 ± 22 ml at surgery. All patients had uncomplicated surgery, and no trough and 32 ± 16 ml at recovery). Depressed myocardial patient sustained an intraoperative infarction. In 96% of function was independent of bypass time, number of grafts patients, significant depression in right and left ventricular placed, preoperative medications or core temperatures ejection fraction was seen postoperatively, reaching a nadir postoperatively. Postoperative therapy with pressors or at 262 ± 116 min after coronary bypass. Left ventricular inotropic agents delayed but did
    [Show full text]
  • Cardiopulmonary Bypass During Pregnancy: a Case Report
    Cardiopulmonary Bypass During Pregnancy: A Case Report Robin G. Sutton and James P. Dearing Medical University of South Carolina Charleston, South Carolina Keywords: case report; pregnancy; technique, cardiopulmonary bypass Abstract _______________ diac operations in pregnant women. II% of the surveys returned included the use of cardiopulmonary bypass. (/. Extra-Corpor. Techno/ 20(2):67-71, 39 refer­ Our recent experience at the Medical University of ences) Reported cases of the pregnant patient dur­ South Carolina with a 21-year-old woman, with congen­ ing cardiopulmonary bypass are rare but not unique. ital aortic stenosis, who was in her second trimester of This case report of the pregnant patient during car­ pregnancy led us to this investigation of the literature. diopulmonary bypass is unique for two reasons. First, the patient was also a Jehovah's Witness and refused Normal Pregnancy blood products. Secondly, this case report provides Even in normal pregnancy there is an increased stress a literature review and specific cardiopulmonary on the heart. Starting from the 8th week of gestation, the bypass considerations pertinent to the perfusionist. blood volume begins to expand. By the 36th week, blood Recent literature reports that heart surgery is rel­ volume is increased to 35 percent above the non-preg­ atively safe during pregnancy. It is important to nant level. The plasma volume is increased by 40 percent monitor fetal heart rate during the procedure not whereas the red blood cell volume has only increased by 2 only to determine fetal distress but also to further 20 percent. By the end of the first trimester, the cardiac knowledge in the area by documenting effects.
    [Show full text]
  • Surgery for Acquired Heart Disease
    View metadata, citation and similar papers at core.ac.uk brought to you byCORE provided by Elsevier - Publisher Connector SURGERY FOR ACQUIRED HEART DISEASE EARLY RESULTS WITH PARTIAL LEFT VENTRICULECTOMY Patrick M. McCarthy, MD a Objective: We sought to determine the role of partial left ventriculectomy in Randall C. Starling, MD b patients with dilated cardiomyopathy. Methods: Since May 1996 we have James Wong, MBBS, PhD b performed partial left ventriculectomy in 53 patients, primarily (94%) in Gregory M. Scalia, MBBS b heart transplant candidates. The mean age of the patients was 53 years Tiffany Buda, RN a Rita L. Vargo, MSN, RN a (range 17 to 72 years); 60% were in class IV and 40% in class III. Marlene Goormastic, MPH c Preoperatively, 51 patients were thought to have idiopathic dilated cardio- James D. Thomas, MD b myopathy, one familial cardiomyopathy, and one valvular cardiomyopathy. Nicholas G. Smedira, MD a As our experience accrued we increased the extent of left ventriculectomy James B. Young, MD b and more complex mitral valve repairs. For two patients mitral valve replacement was performed. For 51 patients the anterior and posterior mitral valve leaflets were approximated (Alfieri repair); 47 patients also had ring posterior annuloplasty. In 27 patients (5!%) one or both papillary muscles were divided, additional left ventricular wall was resected, and the papillary muscle heads were reimplanted. Results: Echocardiography showed a significant decrease in left ventricular dimensions after resection (8.3 cm to 5.8 cm), reduction in mitral regurgitation (2.8+ to 0), and increase in forward ejection fraction (15.7% to 32.7%).
    [Show full text]
  • Arterial Switch Operation Surgery Surgical Solutions to Complex Problems
    Pediatric Cardiovascular Arterial Switch Operation Surgery Surgical Solutions to Complex Problems Tom R. Karl, MS, MD The arterial switch operation is appropriate treatment for most forms of transposition of Andrew Cochrane, FRACS the great arteries. In this review we analyze indications, techniques, and outcome for Christian P.R. Brizard, MD various subsets of patients with transposition of the great arteries, including those with an intact septum beyond 21 days of age, intramural coronary arteries, aortic arch ob- struction, the Taussig-Bing anomaly, discordant (corrected) transposition, transposition of the great arteries with left ventricular outflow tract obstruction, and univentricular hearts with transposition of the great arteries and subaortic stenosis. (Tex Heart Inst J 1997;24:322-33) T ransposition of the great arteries (TGA) is a prototypical lesion for pediat- ric cardiac surgeons, a lethal malformation that can often be converted (with a single operation) to a nearly normal heart. The arterial switch operation (ASO) has evolved to become the treatment of choice for most forms of TGA, and success with this operation has become a standard by which pediatric cardiac surgical units are judged. This is appropriate, because without expertise in neonatal anesthetic management, perfusion, intensive care, cardiology, and surgery, consistently good results are impossible to achieve. Surgical Anatomy of TGA In the broad sense, the term "TGA" describes any heart with a discordant ven- triculoatrial (VA) connection (aorta from right ventricle, pulmonary artery from left ventricle). The anatomic diagnosis is further defined by the intracardiac fea- tures. Most frequently, TGA is used to describe the solitus/concordant/discordant heart.
    [Show full text]
  • Leapfrog Hospital Survey Hard Copy
    Leapfrog Hospital Survey Hard Copy QUESTIONS & REPORTING PERIODS ENDNOTES MEASURE SPECIFICATIONS FAQS Table of Contents Welcome to the 2016 Leapfrog Hospital Survey........................................................................................... 6 Important Notes about the 2016 Survey ............................................................................................ 6 Overview of the 2016 Leapfrog Hospital Survey ................................................................................ 7 Pre-Submission Checklist .................................................................................................................. 9 Instructions for Submitting a Leapfrog Hospital Survey ................................................................... 10 Helpful Tips for Verifying Submission ......................................................................................... 11 Tips for updating or correcting a previously submitted Leapfrog Hospital Survey ...................... 11 Deadlines ......................................................................................................................................... 13 Deadlines for the 2016 Leapfrog Hospital Survey ...................................................................... 13 Deadlines Related to the Hospital Safety Score ......................................................................... 13 Technical Assistance.......................................................................................................................
    [Show full text]
  • Surgical Treatment
    Arch Dis Child: first published as 10.1136/adc.58.2.137 on 1 February 1983. Downloaded from Archives of Disease in Childhood, 1983, 58, 137-141 Congenital heart disease in the neonate: results of surgical treatment E L BOVE, C BULL, J STARK, M DE LEVAL, F J MACARTNEY, AND J F N TAYLOR Thoracic Unit, The Hospitalfor Sick Children, London SUMMARY All 212 neonates undergoing cardiac surgery at this hospital during the 5-year period from 1976 to 1980 inclusive were reviewed. Forty required open heart surgery with 23 (57%) deaths. One hundred and seventy-four neonates underwent non-bypass procedures and could be divided into three groups: group 1 (82 patients) had inadequate pulmonary blood flow, group 2 (33 patients) had increased pulmonary blood flow or inadequate mixing, and group 3 (59 patients) had coarctation of the aorta, alone or with associated lesions. Forty-four (25 %) of the neonates undergoing non- bypass procedures died. Two required bypass surgery later in the first month of life. Metabolic acidosis and the need for preoperative respiratory support were appreciably greater in non-surviving patients. The spectrum of diagnoses encountered and types of operative procedures performed are analysed. Refinements in the surgical treatment of congenital Bypass procedures. Forty patients underwent pro- heart disease in the neonate continue to evolve. cedures involving cardiopulmonary bypass. Neonates copyright. Previous reports of cardiac surgery in the newborn constitute only 3-5 % of our patients undergoing have shown small numbers of patients and a high such operations as the procedures were undertaken operative mortality.1-35-8 The form of treatment only when both the cardiologist and surgeon caring chosen depends on the complexity of the cardiac for the patient felt that survival was unlikely without anomaly as well as the overall condition of the open heart surgery.
    [Show full text]
  • Transcatheter Aortic Valve Replacement
    What is TAVR? Cardiac Catheterization: Important things to know that will help you get ready Transcatheter Aortic Valve Replacement (TAVR) is a procedure Your doctor will tell if you need to stop eating or drinking to fix the aortic valve without taking out the old valve. A TAVR before your procedure. Your doctor also will tell you if you does not need open heart surgery and the heart does not need must stop taking any medications before the procedure. to be stopped. Catheterization Lab In the Pre-Operative (Pre-Op) Room before your The surgeon puts a catheter (thin tube) into an artery in your Cardiac Catheterization upper leg or through a small cut in your chest. The catheter will • You will wear a hospital gown. We will ask you to take off all Transcatheter Aortic Valve carry a new valve to your heart. your clothing (even underwear), jewelry, dentures, glasses, Replacement (TAVR) hearing aids, etc. • An intravenous line (IV) may be put into a vein in your arm • We will prepare and clean the catheter site (where the catheter goes into your body). We will clean your skin with a special wash that kills germs. We may need to trim body hair. • We will ask you to empty your bladder (pee) before your procedure After Your Cardiac Catheterization • You may be on bed rest (lying flat) for 2 to 6 hours. To lower the risk of bleeding, we do not want you to bend your body at the catheter site (where the catheter went into your body) • Your nurse will often check your vital signs (blood pressure, heart rate, temperature) and catheter site • You must use a urinal or bed pan until you can safely stand and walk to the bathroom • While you are healing, do not do strenuous exercise (such as running or lifting weights).
    [Show full text]
  • CARDIOPLEGIA SOLUTION a (Solution)
    NEW ZEALAND DATA SHEET 1 CARDIOPLEGIA SOLUTION A (solution) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1000mL contains the following active substances: Sodium chloride B.P. 6.43g Potassium chloride B.P. 1.19g Magnesium chloride hexahydrate B.P. 3.25g Calcium chloride dihydrate B.P. 176mg The mixture contains the following ions in 1000mL: Sodium 110mmol Magnesium 16mmol Chloride 160mmol Potassium 16mmol Calcium 1.2mmol For the full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Solution. Cardioplegia Solution A is a sterile, non‐pyrogenic solution for cardiac perfusion in a Viaflex bag. It is used to induce cardiac stasis and to protect the myocardium during open‐heart surgery. Cardioplegia Solution A is an isotonic crystalloid solution based on extracellular fluid ionic concentrations. Approximate osmolality is 275mOsm/kg and approximate pH is 3.7. Cardioplegia Solution A requires the aseptic addition of 10mL Sodium Bicarbonate 8.4% w/v Injection B.P. prior to use to adjust the pH to 7.4 ‐ 7.8. Following pH adjustment the total sodium ionic concentration is 120mmol/L. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications Following pH adjustment with 10mL of Sodium Bicarbonate 8.4% w/v Injection B.P., Cardioplegia Solution A is used in combination with ischaemia and hypothermia to induce cardiac arrest during open heart surgery and to preserve the myocardium during asystole. 4.2 Dose and method of administration It is important that an appropriate dose of Cardioplegia Solution A is used to ensure that all areas of the myocardium are cooled evenly, especially those areas distal to arterial obstruction in patients with coronary‐artery disease.
    [Show full text]